1961
DOI: 10.1016/0002-9343(61)90221-2
|View full text |Cite
|
Sign up to set email alerts
|

Hypercholesteremia and nicotinic acid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
7
0
1

Year Published

1961
1961
1998
1998

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 71 publications
(11 citation statements)
references
References 30 publications
3
7
0
1
Order By: Relevance
“…Although generally well tolerated, acipimox therapy induced a slight but significant increase in uric acid concentration (10.3±2.7%). Similar changes have been observed with nicotinic acid [ 21]. Since the risk of gout depends on the absolute concentration [ 22] this increase is clinically irrelevant in patients with normal baseline uric acid concentration.…”
Section: Discussionsupporting
confidence: 59%
“…Although generally well tolerated, acipimox therapy induced a slight but significant increase in uric acid concentration (10.3±2.7%). Similar changes have been observed with nicotinic acid [ 21]. Since the risk of gout depends on the absolute concentration [ 22] this increase is clinically irrelevant in patients with normal baseline uric acid concentration.…”
Section: Discussionsupporting
confidence: 59%
“…We now report that pyrazinoate and nicotinate, another substance that causes urate retention (10), are substrates for the dog renal microvillus membrane anion exchange pathway shared by urate. Moreover, pyrazinoate and nicotinate are also substrates for an organic anion-Na+ cotransport pathway not shared by urate.…”
Section: Introductionmentioning
confidence: 84%
“…Impaired glucose tolerance and the potential adverse effects of the resultant hyperinsulinemia have been described in subjects treated with nicotinic acid 21 , 22 . This appears to be particularly a concern in the case of non‐insulin dependent diabetics when treated with nicotinic acid 21 .…”
Section: Discussionmentioning
confidence: 99%